The direct leucocyte migration inhibition test in capillary tubes was used to test 10 patients with colonic adenocarcinoma against KCl soluble extracts of an allogenic colon cancer and an allogenic normal colon fragment. Inhibition was consistently found with the cancer extract but not with the normal tissue extract. None of the control group of patients affected by other tumors, intestinal and liver disorders showed a migration inhibition in response to the colonic tumor extract. Our findings strongly suggest the presence of a tumor-associated antigen in the cancer extract.
Get full access to this article
View all access options for this article.
References
1.
AkiyoshiT., HataA., TsujiH.: In vitro cellular responses to autologous-tumour extract detected by inhibition of macrophage migration. Gan, 66: 167–174, 1975.
2.
AlexanderP.: Foetal antigens in cancer. Nature, 235: 137, 1972.
3.
AnderssonL.C., GambergC.G.: Different surface glycoprotein patterns on human T–, B– and leukemic-lymphocytes. Int. J. Cancer, 17: 40–46, 1976.
4.
BoddieA.W.Jr., UristM.M., CheeD.O., HolmesE.C., MortonD.L.: Detection of human tumor-associated antigens by the leukocyte migration in agarose assay. Int. J. Cancer, 18: 161–167, 1976.
5.
BoddieA.W.Jr., HolmesE.C., RothJ.A., MortonD.L.: Inhibition of leukocyte migration in agarose by KCl extracts of carcinoma of the lung. Int. J. Cancer, 15: 823–829, 1975.
6.
BoddieA.W.Jr., UristM.M., CheeD.O., HolmesE.C., MortonD.L.: Inhibition of leukocyte migration in agarose by KCl extracts of a human melanoma cell line grown in serum-free medium. Int. J. Cancer, 16: 1035–1041, 1977.
7.
De VriesJ.E., CochrainS., RümkeP.: Cytotoxicity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells. Int. J. Cancer, 14: 427–434, 1974.
8.
FederlinK., MainiR.N., RussellD.S., DumondeD.C.: A micro method for peripheral leukocyte migration in tuberculin sensitivity. J. Clin. Pathol., 24: 533–536, 1971.
9.
FossatiG., ColnaghiM.I., Della PortaG.: Cellular and humoral immunity against human malignant melanoma. Int. J. Cancer, 8: 344–350, 1971.
10.
HellströmI., HellströmK.E., SjögrenH.O., WarnerG.A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer., 7: 1–16, 1971.
11.
HollinsheadA.C., JaffuresW.T., AlpertL.K., HarrisJ.E., HerbermanR.B.: Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells. Cancer Res., 34: 2961–2968, 1974.
12.
HollinsheadA.C., StewartT.H.M., HerbermanR.B.: Delayed hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. J. Natl. Cancer Inst., 52: 327–338, 1974.
13.
LurieB.B., BullD.M., ZamcheckN., StewardA.M., HelmsR.A.: Diagnosis and prognosis in colonic cancer based on a profile of immune reactivity. J. Natl. Cancer Inst., 54: 319–325, 1975.
14.
McCoyJ.L., JeromeL.F., DeanJ.H., PerlinE., OldhamR.K., CharcD.M., CohenM.H., FelixE.L., HerbermanR.B.: Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J. Natl. Cancer Inst., 55: 19–23, 1975.
15.
PeterH.H., SeelandP., DiehlV., EckertG., KaldenJ.R., DercherH.: Serum and cell-mediated cytotoxicity against an allogeneic human melanoma cell. Fed. Proc., 53: 308–319, 1974.
16.
ReisfeldR.A., PellegrinoM.A., KahamB.D.: Salt extraction of soluble HLA antigens. Science, 172: 1134–1136, 1971.
17.
RiecheK., ArendtA., PaternakG.: Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study. Int. J. Cancer, 17: 212–218, 1976.
18.
TakasugiM., MickeyM.R., TerasakiP.I.: Studies on specificity of cell-mediated immunity to human tumors. J. Natl. Cancer Inst., 53: 1537–1538, 1974.
19.
WolbergW.H.: Inhibition of leukocyte migration by human tumors; effect on patients survival. Arch. Surg., 109: 211–214, 1974.
